Learning your genetic risk early enough allows you to take action that could prevent these conditions, or diagnose them earlier at a much more treatable stage, leading to longer, healthier lives and lower treatment costs. For every stage breast cancer is diagnosed earlier, the survival rate increases by 50 percent and treatment costs drop by 30 percent — a potentially crucial source of savings in a country that spent more than $3 trillion on healthcare in 2016.
Genetic testing, in other words, can save both lives and money. But genomic research and the accessibility of testing remain heavily tilted away from minority communities; 80 percent of people whose DNA has been analyzed in scientific research on genetic variants linked to disease are of European descent. Fortunately, efforts are underway to close this genetic equity gap. The UCSF Population Health and Cancer Testing (PHACT) initiative, for instance, recently recruited 500 African-American, Latino and Asian participants in order to study how genetics impact cancer risk in different populations.
Together, Color Genomics and the Morehouse School of Medicine have worked alongside other top research institutions and clinics through the Color For All program that seeks to ensure that genetic testing is available to everyone, regardless of their financial situation. Morehouse’s Health Cancer Health Equity Institute is also conducting laboratory, clinical, and population-based research to better understand, and reduce, cancer health disparities. And its Mobile Clinical Research Unit will aim to bring services and research into the neighborhoods that need them most.
These are all steps in the right direction, but there is much more work to be done. Every healthcare organization, institution and entity must redouble its commitment to expanding research on underserved populations and ensuring these communities’ access to healthcare’s genomics-based future. Let’s make 2018 the year we finally confront the wrong that Dr. King addressed so long ago — and start to set it right.
Dr. Valerie Montgomery Rice is president and dean of the Morehouse School of Medicine. Othman Laraki is co-founder of Color Genomics, a genetics testing company.